238 related articles for article (PubMed ID: 21840879)
1. Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.
Murray AT; Sederberg JH
Semin Cardiothorac Vasc Anesth; 2011; 15(1-2):40-3. PubMed ID: 21840879
[TBL] [Abstract][Full Text] [Related]
2. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
[TBL] [Abstract][Full Text] [Related]
3. Subacute stent thrombosis owing to complete clopidogrel resistance successfully managed with prasugrel.
Flaherty MP; Johnston PV; Rade JJ
J Invasive Cardiol; 2011 Jul; 23(7):300-4. PubMed ID: 21725128
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.
Mohammad RA; Goldberg T; Dorsch MP; Cheng JW
Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
7. Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors.
Sarafoff N; Sibbing D; Sonntag U; Ellert J; Schulz S; Byrne RA; Mehilli J; Schömig A; Kastrati A
Thromb Haemost; 2010 Sep; 104(3):626-32. PubMed ID: 20664905
[TBL] [Abstract][Full Text] [Related]
8. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
[TBL] [Abstract][Full Text] [Related]
9. Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions.
Geisler T; Zürn C; Simonenko R; Rapin M; Kraibooj H; Kilias A; Bigalke B; Stellos K; Schwab M; May AE; Herdeg C; Gawaz M
Eur Heart J; 2010 Jan; 31(1):59-66. PubMed ID: 19812059
[TBL] [Abstract][Full Text] [Related]
10. [Role of bare metal stent in drug eluting stent era].
Takizawa K; Inoue N
Nihon Rinsho; 2011 Feb; 69(2):265-70. PubMed ID: 21387674
[TBL] [Abstract][Full Text] [Related]
11. A current problem in cardiology: very late thrombosis after implantation of sirolimus eluting stent.
Sharifkazemi MB; Zamirian M; Aslani A
Cardiology; 2007; 108(4):273-4. PubMed ID: 17114881
[TBL] [Abstract][Full Text] [Related]
12. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241
[TBL] [Abstract][Full Text] [Related]
13. Perioperative management of a neurosurgical patient with a meningioma and recent coronary artery stent.
Rouine-Rapp K; McDermott MW
J Clin Anesth; 2013 May; 25(3):228-31. PubMed ID: 23688961
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative drug-eluting stent thrombosis in a patient undergoing robotic prostatectomy.
Sharma A; Berkeley A
J Clin Anesth; 2009 Nov; 21(7):517-20. PubMed ID: 20006260
[TBL] [Abstract][Full Text] [Related]
15. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
Chhatriwalla AK; Bhatt DL
Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
[No Abstract] [Full Text] [Related]
16. Late coronary stent thrombosis complicating urologic surgery.
de Korte FI; van Werkum JW; Vijverberg PL; Ten Berg JM
Eur Urol; 2008 Jul; 54(1):221-5; quiz 225. PubMed ID: 17964710
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
19. The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.
Chen TH; Matyal R
Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):256-73. PubMed ID: 21059610
[TBL] [Abstract][Full Text] [Related]
20. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
Ayyanathan S; Hersh D; Coplan NL; Garratt K
Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
